(Source: Virginia Tech - Virginia Polytechnic Institute and State University) ROANOKE, Va., Nov. 16, 2015 - Scientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy. They published their results in Cancer Research, the scientific journal of the American Association of Cancer Research. Glioblastoma accounts for almost half of all brain cancers. Fewer than one in 20 patients survive five years after their diagnosis, and treatment involves surgical removal of the cancerous tissue, followed by chemotherapy. The treatment, although aggressive, typically improves a...
↧